Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Yoshikawa

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
Experimental Dermatology|January 8, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: ProtocolTaku Fujimura, Koji Yoshino, Hiroshi Kato, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|September 22, 2011
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanomaHisashi Uhara, Naoya Yamazaki, Minoru Takata, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
Cancer Genomics & Proteomics|December 27, 2023
Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor MicroenvironmentChikako Hozumi, Akira Iizuka, Tomoatsu Ikeya, et al.
International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.
JCO Global Oncology|September 12, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective StudyShintaro Saito, Masahito Yasuda, Takeshi Araki, et al.
Cancer Medicine|April 2, 2019
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanomaYasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, et al.
Journal of Dermatological Science|April 27, 2019
Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging systemYasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Frontiers in Medicine|August 28, 2023
Efficacy of salvage therapies for advanced acral melanoma after anti-PD-1 monotherapy failure: a multicenter retrospective study of 108 Japanese patientsTatsuhiko Mori, Kenjiro Namikawa, Naoya Yamazaki, et al.
Experimental Dermatology|January 8, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: ProtocolTaku Fujimura, Koji Yoshino, Hiroshi Kato, et al.
European Journal of Cancer (Oxford, England : 1990)|October 4, 2022
Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patientsYasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa, et al.
The Journal of Dermatology|September 22, 2011
Applicability of radiocolloids, blue dyes and fluorescent indocyanine green to sentinel node biopsy in melanomaHisashi Uhara, Naoya Yamazaki, Minoru Takata, et al.
European Journal of Cancer (Oxford, England : 1990)|September 26, 2021
Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter studyYoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa, et al.
Cancer Genomics & Proteomics|December 27, 2023
Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor MicroenvironmentChikako Hozumi, Akira Iizuka, Tomoatsu Ikeya, et al.
International Journal of Clinical Oncology|April 7, 2025
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma studyYasuhiro Fujisawa, Shusuke Yoshikawa, Tatsuya Takenouchi, et al.
JCO Global Oncology|September 12, 2025
Effectiveness and Prognosis of Systemic Chemotherapy for Unresectable Malignant Apocrine and Eccrine Tumors: A Real-World Multicenter Retrospective StudyShintaro Saito, Masahito Yasuda, Takeshi Araki, et al.
Cancer Medicine|April 2, 2019
Clinical and histopathological characteristics and survival analysis of 4594 Japanese patients with melanomaYasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, et al.
Journal of Dermatological Science|April 27, 2019
Classification of 3097 patients from the Japanese melanoma study database using the American joint committee on cancer eighth edition cancer staging systemYasuhiro Fujisawa, Shusuke Yoshikawa, Akane Minagawa, et al.
Pageof 8